ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT06028438

Public ClinicalTrials.gov record NCT06028438. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 11:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a Multicenter, Randomized, Double Blind, Parallel, Proof of Concept Study Evaluating the Efficacy and Safety of Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis Despite Prior Treatment With Advanced Therapies (bDMARD or tsDMARD)

Study identification

NCT ID
NCT06028438
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
103 participants

Conditions and interventions

Interventions

  • Certolizumab Drug
  • Nipocalimab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 14, 2023
Primary completion
Aug 28, 2024
Completion
Oct 28, 2024
Last update posted
Oct 15, 2025

2023 – 2024

United States locations

U.S. sites
10
U.S. states
7
U.S. cities
10
Facility City State ZIP Site status
Arizona Arthritis and Rheumatology Research PLLC Phoenix Arizona 85032
Newport Huntington Medical Group Huntington Beach California 92648
Inland Rheumatology Clinical Trials Inc. Upland California 91786
Bay Area Arthritis and Osteoporosis Brandon Florida 33511
Clinical Research of West Florida Clearwater Florida 33765
Integral Rheumatology And Immunology Specialists Plantation Florida 33324
Atlanta Research Center for Rheumatology Marietta Georgia 30060
Graves Gilbert Clinic Bowling Green Kentucky 42101
Altoona Center For Clinical Research Duncansville Pennsylvania 16635
Southwest Rheumatology Research LLC Mesquite Texas 75150

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06028438, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 15, 2025 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06028438 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →